TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer June 26, 2013
TCL Archive In Brief: Saunders Retires As Dean of UT Graduate School At Galveston; Started Centers Program At NCI August 21, 1987